Literature DB >> 9242697

Role of protein targeting to glycogen (PTG) in the regulation of protein phosphatase-1 activity.

M J Brady1, J A Printen, C C Mastick, A R Saltiel.   

Abstract

We have recently cloned from 3T3-L1 adipocytes a novel glycogen-targeting subunit of protein phosphatase-1, termed PTG (Printen, J. A., Brady, M. J., and Saltiel, A. R. (1997) Science 275, 1475-1478). Differentiation of 3T3-L1 fibroblasts into highly insulin-responsive adipocytes resulted in a marked increase in PTG expression. Immobilized glutathione S-transferase (GST)-PTG fusion protein specifically bound either PP1 or phosphorylase a. Addition of soluble GST-PTG to 3T3-L1 lysates increased PP1 activity against 32P-labeled phosphorylase a by decreasing the Km of PP1 for phosphorylase 5-fold, while having no effect on the Vmax of the dephosphorylation reaction. Alternatively, PTG did not affect PP1 activity against hormone-sensitive lipase. PTG was not a direct target of intracellular signaling, as insulin or forskolin treatment of cells did not activate a kinase capable of phosphorylating PTG in vivo or in vitro. Finally, PTG decreased the ability of DARPP-32 to inhibit PP1 activity from 3T3-L1 adipocyte lysates. These data cumulatively suggest that PTG increases PP1 activity against specific proteins by several distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242697     DOI: 10.1074/jbc.272.32.20198

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Mutations of the serine phosphorylated in the protein phosphatase-1-binding motif in the skeletal muscle glycogen-targeting subunit.

Authors:  J Liu; J Wu; C Oliver; S Shenolikar; D L Brautigan
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

Review 2.  The energy hypothesis of sleep revisited.

Authors:  Matthew T Scharf; Nirinjini Naidoo; John E Zimmerman; Allan I Pack
Journal:  Prog Neurobiol       Date:  2008-09-03       Impact factor: 11.685

Review 3.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

4.  Identification of the separate domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 that interact with phosphorylase a, glycogen and protein phosphatase 1.

Authors:  C G Armstrong; M J Doherty; P T Cohen
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

Review 5.  Deciphering the role of malin in the lafora progressive myoclonus epilepsy.

Authors:  Carlos Romá-Mateo; Pascual Sanz; Matthew S Gentry
Journal:  IUBMB Life       Date:  2012-07-20       Impact factor: 3.885

6.  The level of the glycogen targetting regulatory subunit R5 of protein phosphatase 1 is decreased in the livers of insulin-dependent diabetic rats and starved rats.

Authors:  G J Browne; M Delibegovic; S Keppens; W Stalmans; P T Cohen
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 7.  Spatial determinants of specificity in insulin action.

Authors:  C C Mastick; M J Brady; J A Printen; V Ribon; A R Saltiel
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

8.  AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex.

Authors:  Santiago Vernia; M Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Teresa Rubio; Luisa García-Haro; Marc Foretz; Santiago Rodríguez de Córdoba; Pascual Sanz
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

9.  Darpp-32 and its truncated variant t-Darpp have antagonistic effects on breast cancer cell growth and herceptin resistance.

Authors:  Long Gu; Sarah Waliany; Susan E Kane
Journal:  PLoS One       Date:  2009-07-13       Impact factor: 3.240

10.  Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines.

Authors:  Long Gu; Sean K Lau; Sofia Loera; George Somlo; Susan E Kane
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.